Publications by authors named "Iris Trutzer"

Article Synopsis
  • Improved Overall Survival (OS) and Progression-Free Survival (PFS): Patients with relapsed classic Hodgkin lymphoma (cHL) who received immune checkpoint inhibitors (ICI) before undergoing allogeneic bone marrow transplantation (alloBMT) had significantly better 5-year OS (91%) and PFS (84%) compared to those treated with chemotherapy without ICI (66% OS and 53% PFS).
  • GVHD Incidence and Management: The study found that the incidence of severe graft-versus-host disease (GVHD) was higher in patients who received ICI prior to alloBMT, with a 12-month incidence of grade III-IV GVHD at 20% for the ICI group versus 7%
View Article and Find Full Text PDF

Mantle cell lymphoma (MCL) is frequently diagnosed at advanced stages and is characterized by multiple extranodal sites of disease, most notably the bone marrow, peripheral blood, and gastrointestinal tract. Historically the prognosis of mantle cell lymphoma has been poor with median survival of four to five years. With new treatment regimens, however, patients have been able to achieve prolonged remissions and require special attention while being evaluated for relapse.

View Article and Find Full Text PDF

Autism is a neurodevelopmental connectivity disorder characterized by cortical network disorganization and imbalance in excitation/inhibition. However, little is known about the development of autism pathology and the disruption of laminar-specific excitatory and inhibitory cortical circuits. To begin to address these issues, we examined layer 1 of the lateral prefrontal cortex (LPFC), an area with prolonged development and maturation that is affected in autism.

View Article and Find Full Text PDF

Autism has been linked with the changes in brain connectivity that disrupt neural communication, especially involving frontal networks. Pathological changes in white matter are evident in adults with autism, particularly affecting axons below the anterior cingulate cortices (ACC). It is still unknown whether axon pathology appears early or late in development and whether it changes or not from childhood through adulthood.

View Article and Find Full Text PDF